Inventor · disambiguated record
Cheng Ji
Also filed as: JI CHENG
2 granted patents·12 pending applications·3 citations·filing 2016–2024
47Inventor score
Top patents by PatentIndex Score
14 records- 0189US10676485B2Macrocyclic MCL-1 inhibitors and methods of useABBVIE INC·Filed 2018·Granted Jun 9, 2020·2 cites·2 claims
- 0286US2025313572A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2024·Application pending·0 cites
- 0382US2024228509A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2023·Application pending·0 cites
- 0481US2025092062A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2024·Application pending·0 cites
- 0578US2023399340A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2022·Application pending·0 cites
- 0677US2022259226A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2022·Application pending·0 cites
- 0775US2023183261A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2022·Application pending·0 cites
- 0870US2021292339A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2020·Application pending·0 cites
- 0968US10874686B2Anthranilyl-adenosinemonosulfamate analogs and uses thereofMEMORIAL SLOAN KETTERING CANCER CENTER·Filed 2016·Granted Dec 29, 2020·1 cites·36 claims
- 1068US2020325153A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2020·Application pending·0 cites
- 1165US2020255451A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 1265US2019055264A1Macrocyclic MCL-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 1365US2020239494A1Macrocyclic mcl-1 inhibitors and methods of useABBVIE INC·Filed 2018·Application pending·0 cites
- 1464US2020010480A1Macrocyclic MCL-1 Inhibitors and Methods of UseABBVIE INC·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Cheng Ji files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →